Cannabis oil may reduce the duration and frequency of spasms caused by benign essential blepharospasm (eye twitching), researchers say. The treatment could serve as a second-line treatment for ...
Merz Pharmaceuticals today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Xeomin® (incobotulinumtoxinA), a botulinum toxin type A for the treatment of adults ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback